MARY PARIS: Open Payments
NPI 1790564409 · LOWELL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$542 in 29 payments from 11 companies in 2025. Trend: 2023 $189 · 2024 $681 · 2025 $542
Food & beverage: $542
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $228 |
| PFIZER INC. | 4 | $73 |
| Orexo US, Inc. | 4 | $71 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $49 |
| Indivior Inc. | 1 | $25 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
| Amgen Inc. | 1 | $17 |
| Almatica Pharma LLC | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| Antares Pharma, Inc. | 1 | $14 |
Products named: QULIPTA, UBRELVY, NURTEC ODT, Zubsolv, RELISTOR, SUBLOCADE, VRAYLAR, JOURNAVX.
Industry payments across IN — which companies pay providers there.
